Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study

BACKGROUND: Both light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis are types of cardiac amyloidosis (CA) that require accurate prognostic stratification to plan therapeutic strategies and follow-ups. Cardiac biomarkers, e.g., N-terminal pro-B-type natriuretic peptide (NT-proBNP) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicol, Martin, Vergaro, Giuseppe, Damy, Thibaud, Kharoubi, Mounira, Baudet, Mathilde, Canuti, Elena Sofia, Aimo, Alberto, Castiglione, Vincenzo, Emdin, Michele, Royer, Bruno, Harel, Stephanie, Cohen-Solal, Alain, Arnulf, Bertrand, Logeart, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433216/
https://www.ncbi.nlm.nih.gov/pubmed/37600055
http://dx.doi.org/10.3389/fcvm.2023.1179968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433216/
https://www.ncbi.nlm.nih.gov/pubmed/37600055
http://dx.doi.org/10.3389/fcvm.2023.1179968

Ejemplares similares